
Neurostimulation sham scuppers Mainstay
Mainstay Medical still hopes for US approval of its Reactiv8 device for chronic back pain despite trial failure.
Mainstay Medical still hopes for US approval of its Reactiv8 device for chronic back pain despite trial failure.